tiprankstipranks
Harvard Bioscience (HBIO)
NASDAQ:HBIO

Harvard Bioscience (HBIO) Cash flow

174 Followers

Harvard Bioscience Cash Flow

HBIO's free cash flow for Q3 2023 was $3.96M. For the 2023 fiscal year, HBIO's free cash flow was decreased by $12.15M and operating cash flow was $4.36M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 12.40M$ 14.03M$ 1.15M$ 1.26M$ 9.33M$ 8.04M
Investing Cash Flow
$ -973.00K$ -1.80M$ -1.59M$ -1.34M$ -1.40M$ -229.00K
Financing Cash Flow
$ -10.75M$ -12.13M$ -2.84M$ -252.00K$ -7.97M$ -7.62M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 17.64M$ 4.28M$ 4.51M$ 7.82M$ 8.32M$ 8.34M
Income Tax Paid Supplemental Data
$ 209.00K$ 207.00K$ 534.00K$ 577.00K$ 416.00K$ 374.00K
Interest Paid Supplemental Data
$ 3.79M$ 3.79M$ 2.31M$ 1.58M$ 4.88M$ 5.50M
Issuance Of Capital Stock
------
Issuance Of Debt
$ -8.29M$ -10.54M$ -1.79M$ 50.00K$ 61.31M$ 4.30M
Repayment Of Debt
$ -14.29M$ -15.04M$ -9.59M$ -4.20M$ -66.91M$ -11.70M
Free Cash Flow
$ 10.92M$ 11.72M$ -438.00K$ -83.00K$ 7.93M$ 6.83M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Harvard Bioscience Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis